Erratum to: In vivo quantification of retinal changes associated with drusen in age-related macular degeneration(Invest Ophthalmol Vis Sci., 2015;56:1689–1700, doi:10.1167/iovs.14-16221);In vivo quantification of retinal changes associated with drusen in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 3, 2015, Pages 1689-1700

  Rogala, James ^a,b   Zanger, Barbara ^b   Assaad, Nagi ^b,c   Fletcher, Erica L ^d   Kalloniatis, Michael ^b,d   Nivison Smith, Lisa ^b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age related macular degeneration; Drusen; Optical coherence tomography; Retinal thickness

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUSEN; EYE FUNDUS; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA BIPOLAR GANGLION CELL; RETINA FOVEA; RETINA INNER PLEXIFORM LAYER; RETINA THINNING; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; VISUAL SYSTEM PARAMETERS; MACULAR DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; REFERENCE VALUE; RETINA; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; REFERENCE VALUES; RETINA; RETINAL DRUSEN; STATISTICS AS TOPIC; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84924529061     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-16221a     Document Type: Erratum

References (58)

1. Bourne RR, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol. 2014;98:629-638.
2. Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
3. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653-658.
4. Klein R, Klein BE, Knudtson MD, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006; 113:373-380.
5. Taylor HR, Keeffe JE, Vu HT, et al. Vision loss in Australia. Med J Australia. 2005;182:565-568.
6. Wang JJ, Foran S, Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2000;28:268-273.
7. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011;129:75-80.
8. Nivison-Smith L, Milston R, Madigan M, Kalloniatis M. Age-related macular degeneration: linking clinical presentation to pathology. Opt Vis Sci. 2014;91:832-848.
9. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552-577.
10. Pauleikhoff D. Neovascular age-related macular degeneration:natural history and treatment outcomes. Retina. 2005;25: 1065-1084.
11. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999;5:25.
12. Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
13. Jeganathan VS, Verma N. Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:223-225.
14. Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res. 2005;81:731-741.
15. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:14682-14687.
16. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Oph- thalmol. 1999;83:358-368.
17. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574.
18. Ferris FL III, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120:844-851.
19. Bartlett H, Eperjesi F. Use of fundus imaging in quantification of age-related macular change. Surv Ophthalmol. 2007;52:655-671.
20. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883-1890.
21. Gregori G, Wang F, Rosenfeld PJ, et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology. 2011;118: 1373-1379.
22. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina. 2010;30:1441-1454.
23. Farsiu S, Chiu SJ, O’Connell RV, et al. Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology. 2014;121:162-172.
24. Yi K, Mujat M, Park BH, et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol. 2009;93:176-181.
25. Sadigh S, Cideciyan AV, Sumaroka A, et al. Abnormal thickening as well as thinning of the photoreceptor layer in intermediate age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54:1603-1612.
26. Sadigh S, Luo X, Cideciyan AV, et al. Drusen and photoreceptor abnormalities in African-Americans with intermediate non neovascular age-related macular degeneration. Curr Eye Res. 2014;1-9.
27. Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral- domain optical coherence tomography. Ophthalmology. 2009; 116:488-496.
28. Acton JH, Smith RT, Hood DC, Greenstein VC. Relationship between retinal layer thickness and the visual field in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53:7618-7624.
29. Clark ME, McGwin G Jr, Neely D, et al. Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol. 2011;95:1427-1432.
30. Iwama D, Tsujikawa A, Ojima Y, et al. Relationship between retinal sensitivity and morphologic changes in eyes with confluent soft drusen. Clin Experiment Ophthalmol. 2010;38: 483-488.
31. Landa G, Su E, Garcia PM, Seiple WH, Rosen RB. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina. 2011;31:364-370.
32. Pappuru RR, Ouyang Y, Nittala MG, et al. Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:6743-6748.
33. Wu Z, Ayton LN, Luu CD, Guymer RH. Relationship between retinal microstructures on optical coherence tomography and microperimetry in age-related macular degeneration. Ophthal- mology. 2014;121:1445-1452.
34. Hartmann KI, Gomez ML, Bartsch DU, Schuster AK, Freeman WR. Effect of change in drusen evolution on photoreceptor inner segment/outer segment junction. Retina. 2012;32: 1492-1499.
35. Leuschen JN, Schuman SG, Winter KP, et al. Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. Ophthalmology. 2013;120: 140-150.
36. Karampelas M, Sim DA, Keane PA, et al. Evaluation of retinal pigment epithelium-Bruch’s membrane complex thickness in dry age-related macular degeneration using optical coherence tomography. Br J Ophthalmol. 2013;97:1256-1261.
37. Wood A, Binns A, Margrain T, et al. Retinal and choroidal thickness in early age-related macular degeneration. Am J Ophthalmol. 2011;152:1030-1038.
38. Savastano MC, Minnella AM, Tamburrino A, Giovinco G, Ventre S, Falsini B. Differential vulnerability of retinal layers to early age-related macular degeneration: evidence by SD-OCT segmentation analysis. Invest Ophthalmol Vis Sci. 2014;55: 560-566.
39. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy. Eye. 2005;19:431-441.
40. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:267-273.
41. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.
42. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44:4481-4488.
43. Jamous KF, Kalloniatis M, Hennessy MP, Agar A AH MB, Zangerl B. Clinical model assisting with the collaborative care of glaucoma patients and suspects [published online ahead of print November 2, 2014]. Clin Experiment Ophthalmol. doi:10.1111/ceo.12466.
44. Sallo FB, Rechtman E, Peto T, et al. Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol. 2009;93:1345-1350.
45. Freeman SR, Kozak I, Cheng L, et al. Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina. 2010;30:431-435.
46. Keane PA, Patel PJ, Liakopoulos S, Heussen FM, Sadda SR, Tufail A. Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol. 2012;57: 389-414.
47. Wu Z, Luu CD, Ayton LN, et al. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology. 2014; 121:2415-2422.
48. Sullivan R, Penfold P, Pow DV. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD. Invest Ophthalmol Vis Sci. 2003;44: 856-865.
49. Chua J, Fletcher EL, Kalloniatis M. Functional remodeling of glutamate receptors by inner retinal neurons occurs from an early stage of retinal degeneration. J Comp Neurol. 2009;514: 473-491.
50. Marc RE, Jones BW, Anderson JR, et al. Neural reprogramming in retinal degeneration. Invest Ophthalmol Vis Sci. 2007;48:3364-3371.
51. Sun D, Vingrys AJ, Kalloniatis M. Metabolic and functional profiling of the ischemic/reperfused rat retina. J Comp Neurol. 2007;505:114-130.
52. Lim MC, Hoh ST, Foster PJ, et al. Use of optical coherence tomography to assess variations in macular retinal thickness in myopia. Invest Ophthalmol Vis Sci. 2005;46:974-978.
53. Song WK, Lee SC, Lee ES, Kim CY, Kim SS. Macular thickness variations with sex, age, and axial length in healthy subjects: a spectral domain-optical coherence tomography study. Invest Ophthalmol Vis Sci. 2010;51:3913-3918.
54. Brown B, Tobin C, Roche N, Wolanowski A. Cone adaptation in age-related maculopathy. Am J Optom Phys Optics. 1986;63: 450-454.
55. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49:55-65.
56. Obata R, Yanagi Y. Quantitative analysis of cone photoreceptor distribution and its relationship with axial length, age, and early age-related macular degeneration. PLoS One. 2014;9: e91873.
57. Zayit-Soudry S, Duncan JL, Syed R, Menghini M, Roorda AJ. Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54: 7498-7509.
58. Mrejen S, Sato T, Curcio CA, Spaide RF. Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft Drusen in vivo using adaptive optics imaging. Ophthalmology. 2014;121:545-551.